DFW Clinical Research

1. Taro Pharmaceuticals USA, Inc. $1,268,457 112 payments
2. Teva Pharmaceuticals USA, Inc. $91,000 9 payments
3. Novartis Pharmaceuticals Corporation $24,118 2 payments
4. Pfizer Inc. $22,930 17 payments
5. Sanofi Pasteur Inc. $4,215 2 payments
6. Merck Sharp & Dohme Corporation $3,401 9 payments
7. Sun Pharmaceutical Industries Inc. $1,845 2 payments

1. Study $472,425 32 payments
2. Ta103-2004 $133,650 3 payments
3. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $119,926 8 payments
4. A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Design Group Study to Evaluate the Therapeutic Equivalence Comparing Trifarotene Cream, 0.005% (Teva Pharmaceuticals, Inc. to Aklief (Trifarotene 0.005% Cream) (Galderma Laboratories, L.P., USA), in the Treatment of Acne Vulgaris $91,000 9 payments
5. A Multi-center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.1% (XXXXXX) to Differin Gel (Adapalene 0.1%, Galderma) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris $83,214 6 payments
6. A Multi-center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Tretinoin Cream 0.025% (Taro Pharmaceuticals U.S.A) and RETIN-A (Tretinoin) Cream 0.025% and Both Active Treatment to a Placebo Control in the Treatment of Acne Vulgaris $82,872 6 payments
7. Adbg 1908 $63,324 3 payments
8. A Randomized, Double-Blind, Multiple Center Placebo Controlled Study Comparing Taro Product to RLD and Both Treatments to a Placebo Control in the Treatment of Acne Vulgaris $59,081 5 payments
9. CTBC 1705 $48,987 3 payments
10. THRC 2026 $37,567 4 payments

1. Professional salary support $648,683 38 payments
2. Overhead $12,750 4 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.